Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production

From 2006 to 2011, an average of 15 novel recombinant protein therapeutics have been approved by US Food and Drug Administration (FDA) annually. In addition, the expiration of blockbuster biologics has also spurred the emergence of biosimilars. The increasing numbers of innovator biologic products a...

Full description

Saved in:
Bibliographic Details
Main Authors: Say Kong Ng (Author), Tingfeng Lai (Author), Yuansheng Yang (Author)
Format: Book
Published: MDPI AG, 2013-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available